Grants & Programs

Designated Grants

Through its Designated Grants Program, the Cancer Research Institute administers funding for outside donors who have requested their gifts be directed to certain research areas.


Gar Reichman Program

Through the Gar Reichman Fund, CRI supports the work of Dr. Malcolm A.S. Moore, who heads the Gar Reichman Laboratory and holds the Enid A. Haupt Chair in Cell Biology at Memorial Sloan-Kettering Cancer Center in New York City. Gar Reichman Foundation was established in 1971, in memory of Gar Reichman, to fund research on leukemia and other blood-related diseases. The foundation entrusted its funds to CRI in 1988.

Concern Foundation Program

Since 1981, the Cancer Research Institute and the Concern Foundation for Cancer Research of Beverly Hills in California have provided joint support to the laboratory of Dr. George Klein at the Karolinska Institute in Stockholm, Sweden. Dr. Klein is one of the world’s leading tumor biologists. He and his colleagues have pioneered research into the role of the Epstein-Barr virus in causing Burkitt’s lymphoma (a type of cancer) and other diseases. Moreover, Dr. Klein’s laboratory has been a training center for a large number of outstanding scientists from Russia and other former Communist countries where scientific opportunities have been limited.

CRI is not currently accepting applications for this program.